Immune-mediated dormancy: an equilibrium with cancer

被引:226
作者
Teng, Michele W. L. [1 ]
Swann, Jeremy B. [1 ]
Koebel, Catherine M. [2 ]
Schreiber, Robert D. [2 ]
Smyth, Mark J. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Canc Immunol Program, Trescowthick Labs, Melbourne, Vic 8006, Australia
[2] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA
关键词
immunoediting; elimination; escape;
D O I
10.1189/jlb.1107774
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This brief review discusses the role of the immune system in tumor development, covering a history of cancer immunity and a summary of the concept of cancer immunoediting, including its three phases: elimination, equilibrium, and escape. The latter half of this review then focuses specifically on the equilibrium phase, making note of previous work, suggesting that immunity might maintain cancer in a dormant state, and concluding with a description of a tractable mouse model unequivocally demonstrating that immunity can indeed hold preformed cancer in check. These findings form a framework for future studies aimed at validating immune-mediated cancer dormancy in humans with the hopes of devising new, immunotherapeutic strategies to treat established cancer.
引用
收藏
页码:988 / 993
页数:6
相关论文
共 46 条
[1]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[2]  
CALLAWAY MP, 1989, BRIT J PLAST SURG, V42, P46, DOI 10.1016/0007-1226(89)90111-2
[3]   Anti-idiotype antibodies can induce long-term complete remissions in non-Hodgkin's lymphoma without eradicating the malignant clone [J].
Davis, TA ;
Maloney, DG ;
Czerwinski, DK ;
Liles, TM ;
Levy, R .
BLOOD, 1998, 92 (04) :1184-1190
[4]   Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy [J].
Demicheli, R ;
Abbattista, A ;
Miceli, R ;
Valagussa, P ;
Bonadonna, G .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 41 (02) :177-185
[5]   ENHANCED IN-VIVO GROWTH AND RESISTANCE TO REJECTION OF TUMOR-CELLS EXPRESSING DOMINANT-NEGATIVE IFN-GAMMA RECEPTORS [J].
DIGHE, AS ;
RICHARDS, E ;
OLD, LJ ;
SCHREIBER, RD .
IMMUNITY, 1994, 1 (06) :447-456
[6]   Interferons, immunity and cancer immunoediting [J].
Dunn, Gavin P. ;
Koebel, Catherine M. ;
Schreiber, Robert D. .
NATURE REVIEWS IMMUNOLOGY, 2006, 6 (11) :836-848
[7]   The immunobiology of cancer immunosurveillance and immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
IMMUNITY, 2004, 21 (02) :137-148
[8]   Cancer immunoediting: from immunosurveillance to tumor escape [J].
Dunn, GP ;
Bruce, AT ;
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2002, 3 (11) :991-998
[9]   The three Es of cancer immunoediting [J].
Dunn, GP ;
Old, LJ ;
Schreiber, RD .
ANNUAL REVIEW OF IMMUNOLOGY, 2004, 22 :329-360
[10]  
Farrar JD, 1999, J IMMUNOL, V162, P2842